Overview

AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of the study drug, AEGR-733 alone and in combination with the medication, atorvastatin (Lipitor), on cholesterol in volunteers with moderately high cholesterol.
Phase:
Phase 2
Details
Lead Sponsor:
Aegerion Pharmaceuticals, Inc.
Treatments:
Atorvastatin
Atorvastatin Calcium